Genetic Analysis AS (XSAT:GEAN)

Genetic Analysis AS Statistics

Total Valuation

XSAT:GEAN has a market cap or net worth of SEK 44.15 million. The enterprise value is 28.48 million.

Market Cap	44.15M
Enterprise Value	28.48M

Important Dates

The next confirmed earnings date is Thursday, May 28, 2026.

Earnings Date	May 28, 2026
Ex-Dividend Date	n/a

Share Statistics

XSAT:GEAN has 69.09 million shares outstanding. The number of shares has increased by 41.67% in one year.

Current Share Class	69.09M
Shares Outstanding	69.09M
Shares Change (YoY)	+41.67%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	12.71%
Owned by Institutions (%)	14.91%
Float	20.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.28
PB Ratio	1.78
P/TBV Ratio	1.81
P/FCF Ratio	23.57
P/OCF Ratio	20.11
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.73
EV / Sales	1.33
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	15.20

Financial Position

The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.32.

Current Ratio	1.64
Quick Ratio	1.57
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	4.19
Interest Coverage	-22.18

Financial Efficiency

Return on equity (ROE) is -46.05% and return on invested capital (ROIC) is -20.15%.

Return on Equity (ROE)	-46.05%
Return on Assets (ROA)	-14.47%
Return on Invested Capital (ROIC)	-20.15%
Return on Capital Employed (ROCE)	-32.80%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.08M
Profits Per Employee	-579,747
Employee Count	16
Asset Turnover	0.45
Inventory Turnover	6.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.55% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-56.55%
50-Day Moving Average	0.65
200-Day Moving Average	0.75
Relative Strength Index (RSI)	47.97
Average Volume (20 Days)	30,446

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, XSAT:GEAN had revenue of SEK 19.36 million and -10.44 million in losses. Loss per share was -0.16.

Revenue	19.36M
Gross Profit	15.06M
Operating Income	-10.04M
Pretax Income	-10.44M
Net Income	-10.44M
EBITDA	-9.86M
EBIT	-10.04M
Loss Per Share	-0.16

Balance Sheet

The company has 21.97 million in cash and 7.84 million in debt, with a net cash position of 14.13 million or 0.20 per share.

Cash & Cash Equivalents	21.97M
Total Debt	7.84M
Net Cash	14.13M
Net Cash Per Share	0.20
Equity (Book Value)	24.76M
Book Value Per Share	0.36
Working Capital	11.07M

Cash Flow

In the last 12 months, operating cash flow was 2.20 million and capital expenditures -321,850, giving a free cash flow of 1.87 million.

Operating Cash Flow	2.20M
Capital Expenditures	-321,850
Depreciation & Amortization	202,769
Net Borrowing	-1.86M
Free Cash Flow	1.87M
FCF Per Share	0.03

Margins

Gross margin is 77.80%, with operating and profit margins of -51.86% and -53.91%.

Gross Margin	77.80%
Operating Margin	-51.86%
Pretax Margin	-53.91%
Profit Margin	-53.91%
EBITDA Margin	-50.92%
EBIT Margin	-51.86%
FCF Margin	9.68%

Dividends & Yields

XSAT:GEAN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.67%
Shareholder Yield	-41.67%
Earnings Yield	-23.64%
FCF Yield	4.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

XSAT:GEAN has an Altman Z-Score of 0.47 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.47
Piotroski F-Score	4